MI-BP: mHealth to Improve Blood Pressure Control in Hypertensive African Americans
Status: | Recruiting |
---|---|
Conditions: | High Blood Pressure (Hypertension) |
Therapuetic Areas: | Cardiology / Vascular Diseases |
Healthy: | No |
Age Range: | 25 - 70 |
Updated: | 9/28/2018 |
Start Date: | January 11, 2018 |
End Date: | June 2020 |
Contact: | Reema Kadri, MLIS |
Email: | rkadri@med.umich.edu |
Phone: | 734-998-7120 |
This study seeks to evaluate a multicomponent mobile intervention to change multiple
hypertension-related health behaviors in African Americans with uncontrolled hypertension.
Half of the participants will receive a mobile intervention designed to improve physical
activity, sodium intake, and medication adherence. The other half will receive usual care.
hypertension-related health behaviors in African Americans with uncontrolled hypertension.
Half of the participants will receive a mobile intervention designed to improve physical
activity, sodium intake, and medication adherence. The other half will receive usual care.
Inclusion Criteria:
- African American
- Hypertensive
- Owning a compatible smartphone
- Presenting to the Detroit Medical Center Detroit Receiving or Sinai-Grace Hospital
with, but not necessarily for, uncontrolled blood pressure (systolic blood pressure ≥
135 mm Hg at triage and on repeat measurement using the BpTRU device)
Exclusion Criteria:
- No self-reported prior history of hypertension
- No hypertension diagnosis documented in their medical record
- Non-English speaking
- Presenting with an acute illness necessitating immediate medical intervention
- Presenting with an admission to the hospital for critical reasons (as determined by
the attending physician)
- Pregnant (as determined by a dip test at screening), or self-report during trial.
- Having the following serious comorbidities or confounders due to the fact that they
may make blood pressure control difficult or necessitate frequent Emergency Department
use or hospitalization:
- Previous diagnosis of resistant hypertension (or current use of 3 or more
maximally dosed antihypertensive agents without achievement of blood pressure
control)
- Steroid dependent asthma or emphysema
- Cirrhosis or hepatic failure
- Chronic heart failure (any stage)
- Previous diagnosis of acute myocardial infarction, angina (stable or unstable),
or known coronary artery disease
- Previous diagnosis of cerebrovascular disease (including transient ischemic
attack or stroke)
- Known valvular heart disease
- Stage IV or V chronic kidney disease
- Cancer (terminal or undergoing active chemotherapeutic or radiation therapy)
- Patients with other serious medical conditions that may affect their ability to
self-monitor blood pressure (such a dementia)
- Having a history of alcohol or drug abuse as determined by the CAGE-AID questionnaire
(excluded if 2 or more)
- Week 0 measurement of systolic blood pressure < 130 mm Hg using the BpTRU device
We found this trial at
2
sites
5050 Anthony Wayne Dr
Detroit, Michigan 48201
Detroit, Michigan 48201
(313) 577-2424
Principal Investigator: Phillip Levy, MD, MPH
Wayne State University Founded in 1868, Wayne State University is a nationally recognized metropolitan research...
Click here to add this to my saved trials
University of Michigan The University of Michigan was founded in 1817 as one of the...
Click here to add this to my saved trials